| Dendritic cells and cancer immunity A Gardner, B Ruffell Trends in immunology 37 (12), 855-865, 2016 | 780 | 2016 |
| Dendritic Cells and Their Role in Immunotherapy A Gardner, Á de Mingo Pulido, B Ruffell Frontiers in Immunology 11, 924, 2020 | 318 | 2020 |
| TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer Á de Mingo Pulido, A Gardner, S Hiebler, H Soliman, HS Rugo, ... Cancer cell 33 (1), 60-74. e6, 2018 | 303 | 2018 |
| The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake Á de Mingo Pulido, K Hänggi, DP Celias, A Gardner, J Li, ... Immunity 54 (6), 1154-1167. e7, 2021 | 121 | 2021 |
| TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization A Gardner, Á de Mingo Pulido, K Hänggi, S Bazargan, A Onimus, ... Journal for Immunotherapy of Cancer 10 (1), 2022 | 25 | 2022 |
| A novel role for transcription-coupled nucleotide excision repair for the in vivo repair of 3,N4-ethenocytosine IA Chaim, A Gardner, J Wu, T Iyama, DM Wilson III, LD Samson Nucleic acids research 45 (6), 3242-3252, 2017 | 19 | 2017 |
| Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy DK Lester, C Burton, A Gardner, P Innamarato, K Kodumudi, Q Liu, ... Nature Cancer 4 (2), 222-239, 2023 | 16 | 2023 |
| Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC AE Schade, R Kuzmickas, CL Rodriguez, K Mattioli, M Enos, A Gardner, ... Plos Biology 21 (4), e3002038, 2023 | 8 | 2023 |
| moDCs, Less Problems A Gardner, B Ruffell Immunity 48 (1), 6-8, 2018 | 6 | 2018 |
| DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer AL Miller, N Perurena, A Gardner, T Hinoue, P Loi, PW Laird, K Cichowski Cancer Research 83 (11), 1800-1814, 2023 | 1 | 2023 |
| A novel role for transcription-coupled nucleotide excision repair for the in vivo repair of 3, N [superscript4]-ethenocytosine IA Chaim, A Gardner, J Wu, T Iyama, DM Wilson, LD Samson Oxford University Press, 2017 | 1 | 2017 |
| Abstract B072: Loss of the tumor and metastasis suppressor RasGAP DAB2IP mediates therapeutic resistance in HER2+ breast cancer N Perurena, A Schade, N Pilla, P Loi, C Rodriguez, A Gardner, ... Cancer Research 84 (3_Supplement_1), B072-B072, 2024 | | 2024 |
| Necroptosis promotes tumor growth through IL1-alpha release and recruitment of immunosuppressive myeloid cells K Hänggi, A Keske, A Gardner, J Li, O Osunmakinde, D Celias, A Beg, ... Cancer Research 83 (7_Supplement), 655-655, 2023 | | 2023 |
| Abstract P1-13-06: Loss of emerging tumor and metastasis suppressor RasGAPs mediates therapeutic resistance in HER2+ breast cancer N Perurena, N Pilla, A Schade, M Watanabe, P Loi, CL Rodriguez, ... Cancer Research 83 (5_Supplement), P1-13-06-P1-13-06, 2023 | | 2023 |
| Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy E Lau, D Lester, C Burton, A Gardner, P Innamarato, K Kodumudi, Q Liu, ... | | 2022 |
| Determining the Role of Dendritic Cells during Response to Treatment with Paclitaxel/Anti-TIM-3 A Gardner University of South Florida, 2022 | | 2022 |
| TIM-3 suppresses CD103+ dendritic cell function and response to chemotherapy in breast cancer. AM Pulido, A Gardner, S Hiebler, H Soliman, HS Rugo, MF Krummel, ... MOLECULAR CANCER RESEARCH 16 (8), 39-39, 2018 | | 2018 |
| TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. A Gardner, S Hiebler, H Soliman, HS Rugo, MF Krummel, LM Coussens, ... Cancer cell 33 (1), 60-74. e6, 2018 | | 2018 |
| Reducing interferon'ce in stem cells A Gardner, B Ruffell Nature Cell Biology 19 (6), 597-599, 2017 | | 2017 |
| Potential Therapeutic Relevance For TIM-3 In Breast Cancer Patients A Gardner Science Trends, 0 | | |
